Data / Form D filings / BTB Therapeutics, Inc.
BTB Therapeutics, Inc.: Form D filings
BTB Therapeutics, Inc., a pharmaceuticals company in Escondido, CA, filed 3 Form D notices with the SEC between 2025 and 2026. The latest, on August 12, 2026, reports $8.9 million sold of a $10.4 million offering to 4 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 26281 WYNDEMERE COURT, Escondido, CA, 92026
- Phone
- (858) 945-3733
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2024
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2055053
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 12, 2026 | Amendment | $10,402,704 | $8,902,204 | $1,500,500 | 4 | Nov 14, 2025 | sec.gov |
| Dec 1, 2025 | New notice | $7,402,704 | $3,402,704 | $4,000,000 | 4 | Nov 14, 2025 | sec.gov |
| Feb 5, 2025 | New notice | $3,333,415 | $3,333,333 | $82 | 10 | Jan 30, 2025 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Takashi Kiyoizumi | Executive Officer, Director | |
| Nobuhiro Yagi | Director | |
| Masatoshi Hagiwara | Director | |
| David Snyder | Director | |
| Sidney Yee | Director |
Other pharmaceuticals companies in California that filed recently
- Anvion Bio, Inc. $100,000 · Oct 7, 2026
- Aqur Biosciences, Inc. $1.5 million · Sep 18, 2026
Every Form D from the week of Aug 10, 2026 · All recent filings in California · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what BTB Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.